By Daniella Parra ActivePure Medical said a study showed its air decontamination system significantly reduces healthcare-associated infections and was published in the American Journal of Infection Control. The study showed a 96-99% reduction in methicillin-resistant Staphylococcus aureus (MRSA) and a...

By Karen Roman Edgewell Personal Care Co. (NYSE: EPC) updated its full year outlook to an adjusted EBITDA of approximately $356 million, compared with a previous range of $348 to $360 million. The maker of Schick brand razors said third...

By Karen Roman Pharmaceutical company Aspargo Laboratories released a Phase 1 study showing its oral spray for erectile dysfunction achieves absorption within five minutes, twice as fast as existing sildenafil tablets. ASP-001 uses sildenafil, the active ingredient in Viagra (Nasdaq:...

By Daniella Parra Nanox Imaging Ltd. said that its AI Cardiac Solution (HealthCCSng) was showcased at SCCT 2024. Corewell Health’s study showed HealthCCSng identified 3,721 new patients with significant CAC in one year, improving patient outcomes and compliance. Jefferson Einstein...

By Daniella Parra Agilent Technologies (NYSE: A) said it’s acquiring BIOVECTRA, a Canadian CDMO, for $925 million. The company said it will enhance Agilent’s biopharma solutions by expanding service offerings, adding expertise in fast-growing segments like ADCs and HPAPIs, and strengthening...

By Karen Roman The deadline to vote in favor of an $8 billion settlement in a class action lawsuit against Johnson & Johnson (NYSE: JNJ) regarding its talcum powder products is 5pm ET Friday, leaving claimants just hours to act. ...

By Daniella Parra Haystack Oncology and Lisata Therapeutics (Nasdaq: LSTA) are jointly researching the efficacy of a pancreatic cancer therapy, they said. The study will test Lisata’s drug, certepetide, combined with chemotherapy in patients with metastatic pancreatic cancer and Haystack’s...

By Karen Roman Conduit Pharmaceuticals Inc. (Nasdaq: CDT) said IP Australia approved a patent application for an activator targeting autoimmune diseases. This should open the path to approvals in other countries, Conduit said in a statement. “With up to 20...

By Daniella Parra Aktis Oncology said it appointed Akos Czibere, MD, PhD, as Chief Medical Officer. Dr. Czibere has overseen several functional areas in his nearly 20-year career, filed a number of new drug applications and successfully led multiple global...

By Daniella Parra Agilent Technologies, Inc. (NYSE: A) has appointed Bret DiMarco as senior vice president and chief legal officer, also serving as secretary, the company announced Monday. DiMarco, previously the chief legal officer at Pendo.io, has extensive legal and...